Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease

NCT07452822 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Arteriovenous Fistula Stenosis

Interventions

BIOLOGICAL: Human umbilical cord mesenchymal stem cells injection
OTHER: saline solution

Sponsor

Jiangsu Topcel-KH Pharmaceutical Co., Ltd.